The report lists Bajaj Auto among the top gainers, up 2.42-6.78%.
Read this note →Research notes
What India's research desks published, reported with attribution and linked to the original notes. Orivam issues no recommendations of its own.
All houses
HDFC Securities
Motilal Oswal
Tata Asset Management
Mirae Asset Sharekhan
India IPO
Jainam
GEPL Capital
Way2Wealth
SBICAP Securities
Angel One
Axis Securities
ICICI Direct Research Retail
Religare
Arete Securities
Formerly known as Way2Wealth
ICICI Direct
Way2Wealth Securities
quant Mutual Fund
ICICI Securities
Kotak Securities
JM Financial
ICICI Securities – Retail
Ventura Securities
Global Markets by Vested
Prabhudas Lilladher
ITC Hotels
Elara Securities
Exterminators PLC
Emkay Global
Industrial Asphalts
Private Client Group Research summarized from KIE research report
Kahawatte Plantations PLC
2525 notes · all time
The report lists Bharti Airtel among the top gainers, up 2.42-6.78%.
Read this note →The report lists Tata Consumer Products among the top gainers, up 2.42-6.78%.
Read this note →The report lists MAZDOCK under short build up in the market monitor section.
Read this note →The report lists AUBANK under short build up in the market monitor section.
Read this note →The report lists WAAREEENER under short build up in the market monitor section.
Read this note →The report lists UPL under long build up in the market monitor section.
Read this note →The report lists MOTILALOFS under long build up in the market monitor section.
Read this note →The report lists UNITDSPR under long build up in the market monitor section.
Read this note →The report states an ADD rating on Max Healthcare.
Read this note →The report states an ADD rating on Aster DM.
Read this note →The report states a BUY rating on Apollo Hospitals.
Read this note →The report maintains a BUY rating with a Sep-27 target price of INR 5,300, citing strong Q2FY27 execution with revenue up 17%, EBITDA up 50%, and earnings up 67%, driven by premiumization and raised FY27 P&A volume growth guidance to 30%.
Read this note →The report says IndiaMart delivered a moderate quarter with ARPU-led growth offsetting declining paying subscribers, maintaining ADD with a DCF-based TP of INR 1,900.
Read this note →The report says Acutaas Chemicals beat Q2 estimates on EBITDA/APAT but maintains SELL due to high near-term valuations, with TP of INR 2,427.
Read this note →The report says JK Cement delivered strong volume growth and EBITDA growth in Q2FY27, maintaining BUY with unchanged TP of INR 6,130.
Read this note →The report says MDL posted a disappointing quarter with declining revenue and EBITDA due to weak order book execution, but maintains a long-term constructive ADD rating with reduced multiple and TP of INR 2,300.
Read this note →The report says Tata Capital's Q2FY27 earnings beat estimates on lower credit costs and AUM growth despite NIM compression, maintaining ADD with a revised TP of INR 365.
Read this note →The report says SBI Life beat estimates on APE/VNB growth and margin expansion from product mix shift, maintaining a high-conviction BUY with revised TP of INR2,320.
Read this note →The report says L&T beat revenue and APAT estimates with record order book and robust order inflows, maintaining BUY with a revised SOTP target of INR 4,680.
Read this note →Under CTFT, the report notes a Buy call on Max Healthcare where profit was booked at 846.85, with listed targets of 850 and 860.
Read this note →Under CTFT, the report lists an ongoing Buy call on Birla Corporation entered at 804.70 with stop loss 790, current price 800.05, and targets of 820 and 835.
Read this note →Under CTFT, the report notes a Buy call on ABREL that was stopped out at 1,080, against an entry of 1,107.
Read this note →Under CTFT, the report notes a Buy call on Karur Vysya Bank where profit was booked at 351.50, with listed targets of 352 and 358.
Read this note →Under Momentum Swing, the report notes a Buy call on Phoenix Mills Nov futures that was exited at 1,919.30, with listed targets of 1,945 and 1,970.
Read this note →